Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- ICEGATE and GST Portal Mismatch? Complete IGST Refund Solution Guide
- How to Resolve Customs Clearance Delay Due to Dual Use NOC Issue Quickly
- Advance Authorisation License Pending Status? Complete Solution Guide for 2026
- Top Advance Authorization Application Rejection Reasons and How to Avoid Them
- Battery Waste EPR Portal Errors: Complete Troubleshooting Guide for Businesses
- How to Calculate E-Waste EPR Targets and Compliance Obligations
- EPR Registration vs EPR Compliance: What PIBOs Must Know in 2026
- Battery Waste EPR Registration for Importers in India: Complete 2026 Compliance Guide
FeATURED ARTICLES
SARAL SIMS for Steel Imports in India – Complete Guide The Government of India has introduced SARAL SIMS (Simplified Steel…
Top Export Compliance Mistakes: DGFT Advance Authorization, EPCG & CPCB (2025 Guide) Exporting in India can feel like a legal…
Environmental Clearance CPCB: Quick Guide for Exporters If you’re an Indian exporter or manufacturer working under schemes like the Advanced…
DGFT e-BRC Rule 2025: Key Update for Advance Authorization & EPCG Holders The Directorate General of Foreign Trade (DGFT) has…

